Skip to content

Clinical trials

Completed Phase 2/3 Major Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 2/3 Status: Completed Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20073
20083
20092
20105
20114
20121
20132
20141
20153
20161
20172
20181
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo4
Douglas Mental Health University Institute3
New York State Psychiatric Institute2
Bo Hu1
Brain and Cognition Discovery Foundation1
Duke University1
Eli Lilly and Company1
Euthymics BioScience, Inc.1
Laureate Institute for Brain Research, Inc.1
Marta Peciña, MD PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder32
Depressive Disorder6
Bipolar Disorder2
Depressive Disorder, Treatment-Resistant2
Mood Disorders2
Alzheimer Disease1
Anorexia1
Anxiety Disorders1
Cardiovascular Diseases1
Cognitive Dysfunction1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.